Furosemide ( DrugBank: Furosemide )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
6. パーキンソン病
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04706910 (ClinicalTrials.gov) | January 20, 2021 | 21/12/2020 | 18F-DOPA II - PET Imaging Optimization | 18F-DOPA II - PET Imaging Optimization | Congenital Hyperinsulinism;Neuroblastoma;Parkinson Disease;Lewy Body Disease;Neuroendocrine Tumors;Brain Tumor | Drug: 18F-DOPA;Drug: Furosemide Injection | University of Alberta | NULL | Recruiting | N/A | N/A | All | 800 | Phase 3 | Canada |